Browse > Article

Three Cases of Central Nervous System Infection Caused by Multi-Drug-Resistant Acinetobacter baumannii  

Kim, Eun-Yeong (Department of Internal Medicine, Kyung Hee University School of Medicine)
Moon, Song-Mi (Department of Internal Medicine, Kyung Hee University School of Medicine)
Kim, Yeon-Ju (Department of Internal Medicine, Kyung Hee University School of Medicine)
Park, Hyun-Jin (Department of Internal Medicine, Kyung Hee University School of Medicine)
Son, Jun-Seong (Department of Internal Medicine, Kyung Hee University School of Medicine)
Lee, Mi-Suk (Department of Internal Medicine, Kyung Hee University School of Medicine)
Publication Information
The Korean Journal of Medicine / v.80, no.1, 2011 , pp. 118-121 More about this Journal
Abstract
In recent years, Acinetobacter baumannii has become an increasingly common nosocomial pathogen. It causes rare, but severe, central nervous system (CNS) infection, especially in patients undergoing neurosurgical procedures or with head trauma. Multi-drug-resistant A. baumannii (MDR-AB) has emerged as a pathogen causing CNS infection. We describe A. baumannii CNS infections seen during the last 5 years and focus on MDR-AB CNS infection. Seven patients were admitted to the neurosurgical intensive care unit with serious head injuries. Imipenem-susceptible A. baumannii was identified in all four cases seen from 2003 to 2006, whereas the three cases seen from 2007 to 2008 were MDR-AB CNS infections. Two cases of MDR-AB CNS infection were cured with intraventricular or intrathecal colistin without any side effects. Therefore, intraventricular or intrathecal colistin should be considered for MDR-AB CNS infection. Studies of the dose and duration of intraventricular and intrathecal administration are needed.
Keywords
Acinetobacter baumannii; Central nervous system infections; Colistin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wolff MA, Young CL, Ramphal R. Antibiotic therapy for enterobacter meningitis: a retrospective review of 13 episodes and review of the literature. Clin Infect Dis 1993;16:772-777.   DOI   ScienceOn
2 Rahal JJ, Simberkoff MS. Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis. Ann Intern Med 1982;96:468-474.   DOI   ScienceOn
3 Katragkou A, Roilides E. Successful treatment of multidrugresistant acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol 2005;43:4916-4917.   DOI   ScienceOn
4 Ho YH, Wang LS, Chao HJ, Chang KC, Su CF. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect. 2007;40:537-540.
5 Go ES, Urban C, Burns J, et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994;344:1329-1332.   DOI   ScienceOn
6 Kuo LC, Teng LJ, Yu CJ, Ho SW, Hsueh PR. Dissemination of a clone of unusual phenotype of pandrug-resistant acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol 2004;42:1759-1763.   DOI   ScienceOn
7 Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis 2006;6:589-601.   DOI   ScienceOn
8 Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK. Cure of multiresistant acinetobacter baumannii CNS infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 2006;58:1078-1081.   DOI   ScienceOn
9 Paramythiotou E, Karakitsos D, Aggelopoulou H, Sioutos P, Samonis G, Karabinis A. Post-surgical meningitis due to multiresistant acinetobacter baumannii: effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med Mal Infec 2007;37:124-125.   DOI   ScienceOn
10 Jimenez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002;21:212-214.   DOI   ScienceOn
11 Rodriguez Guardado A, Blanco A, Asensi V, et al. Multidrug-resistant acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 2008;61:908-913.   DOI   ScienceOn
12 Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant gram-negative bacteria. Int J Antimicrob Agents 2005;25:11-25.   DOI   ScienceOn